MLTX Moonlake Immunotherapeutics

Fundamentals / CIK 0001821586 / USD

Moonlake Immunotherapeutics reported $540.7M in total assets and a net loss of $273.5M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open MLTX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

5 fiscal years (2021 to 2025), reported in USD.

$0$0$0-$212.5MFY 2021 Net Income: -$4.54M2021FY 2022 Net Income: -$49.97M2022FY 2023 Net Income: -$36.01M2023FY 2024 Net Income: -$118.9M2024FY 2025 Net Income: -$227.3M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $202.9M $112.8M $31.80M $42.05M --
Total Operating Expenses $244.8M $143.1M $54.12M $65.06M --
Operating Income -$244.8M -$143.1M -$54.12M -$65.06M -$4.57M
EBITDA -$242.2M -$141.7M -$53.75M -$64.90M --
Interest Income -- -- -- -- $28K
Interest Expense $7.25M $0 $0 -- --
Income Before Tax -$229.7M -$121.0M -$43.98M -$64.47M --
Income Tax Expense $611K $282K $94K $36K --
Net Income -$227.3M -$118.9M -$36.01M -$49.97M -$4.54M
Basic EPS -$3.53 -$1.89 -$0.73 -$1.70 -$0.31
Diluted EPS -$3.53 -$1.89 -$0.73 -$1.70 -$0.31
Basic Shares Outstanding 64.5M 62.9M 49.1M 29.4M 11.9M
Diluted Shares Outstanding 64.5M 62.9M 49.1M 29.4M 360.0M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $68.87M $50.22M $54.52M $56.01M $60.63M $49.76M $36.46M $40.36M
Total Operating Expenses $79.85M $61.66M $70.02M $65.22M $71.43M $60.70M $47.48M $49.58M
Operating Income -$79.85M -$61.66M -$70.02M -$65.22M -$71.43M -$60.70M -$47.48M -$49.58M
EBITDA -$78.95M -$60.76M -$69.18M -$64.47M -$70.69M -$59.96M -$47.11M -$49.22M
Interest Expense $2.65M $2.63M $2.27M $1.99M $3.20M $2.04M $18K $0
Income Tax Expense $631K $90K $622K $248K $115K $95K $153K $41K
Net Income -$79.55M -$61.80M -$69.71M -$62.43M -$69.73M -$55.22M -$39.94M -$45.60M
Basic EPS -$0.93 -$0.84 -$0.98 -- -$1.10 -$0.87 -$0.63 --
Diluted EPS -$0.93 -$0.84 -$0.98 -- -$1.10 -$0.87 -$0.63 --
Basic Shares Outstanding 85.4M 73.9M 71.3M -- 63.4M 63.3M 63.2M --
Diluted Shares Outstanding 85.4M 73.9M 71.3M -- 63.4M 63.3M 63.2M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $334.5M $180.4M $451.2M $39.51M $8.04M $1.34M
Short-Term Investments $59.45M $267.6M $59.84M $32.61M $0 --
Cash & Short-Term Investments $394.0M $448.0M $511.0M $72.11M $8.04M $1.34M
Other Current Assets $4.87M -- -- -- -- --
Total Current Assets $421.7M $474.3M $514.2M $76.51M $9.64M $1.62M
Property, Plant & Equipment, Net $577K $722K $321K $49K $46K --
Other Non-Current Assets $596K $0 -- -- -- --
Total Non-Current Assets $2.74M $3.64M $12.37M $332K $46K $115.0M
Total Assets $424.4M $477.9M $526.5M $76.84M $9.68M $116.6M
Short-Term Debt -- -- -- $0 $15.00M --
Total Current Liabilities $45.48M $22.46M $9.97M $7.67M $21.09M $125K
Long-Term Debt $74.10M $0 -- -- -- --
Total Non-Current Liabilities $74.47M $2.08M $3.08M $411K $240K $4.03M
Total Liabilities $120.0M $24.54M $13.05M $8.08M $21.33M $4.15M
Total Debt (incl. Leases) $75.71M $2.83M $3.70M $283K $15.00M --
Common Stock -- -- -- -- $43 $43
Retained Earnings -$462.9M -$235.6M -$116.7M -$80.65M -$53.64M -$2.52M
Accumulated Other Comp. Income $604K $5.00M $2.36M $351K -$168K --
Total Stockholders' Equity $304.5M $446.8M $495.7M $48.90M -$11.65M -$2.52M
Total Equity $304.5M $453.4M $513.5M $68.77M -$11.65M -$2.52M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $379.7M $477.9M $298.5M $334.5M $350.7M $306.7M $271.6M $180.4M
Short-Term Investments $118.8M $59.12M $59.43M $59.45M $29.74M $118.4M $208.6M $267.6M
Cash & Short-Term Investments $498.5M $537.0M $357.9M $394.0M $380.5M $425.1M $480.1M $448.0M
Other Current Assets $8.95M -- -- $4.87M -- -- -- --
Total Current Assets $533.3M $570.0M $396.6M $421.7M $411.2M $455.5M $506.3M $474.3M
Property, Plant & Equipment, Net $443K $487K $532K $577K $622K $667K $711K $722K
Other Non-Current Assets $5.22M $1.34M $1.34M $596K $587K $1.70M $1.70M $0
Total Non-Current Assets $7.37M $3.91M $3.73M $2.74M $3.12M $4.62M $5.00M $3.64M
Total Assets $540.7M $573.9M $400.4M $424.4M $414.3M $460.1M $511.3M $477.9M
Total Current Liabilities $58.43M $45.39M $46.11M $45.48M $48.37M $27.36M $23.98M $22.46M
Long-Term Debt $100.0M $99.51M $99.02M $74.10M $73.74M $73.38M $73.02M $0
Total Non-Current Liabilities $100.7M $100.4M $100.2M $74.47M $74.78M $74.79M $74.70M $2.08M
Total Liabilities $159.1M $145.8M $146.3M $120.0M $123.1M $102.2M $98.68M $24.54M
Total Debt (incl. Leases) $101.6M $101.5M $100.8M $75.71M $75.73M $75.77M $75.60M $2.83M
Retained Earnings -$674.0M -$594.4M -$532.6M -$462.9M -$400.5M -$330.8M -$275.5M -$235.6M
Accumulated Other Comp. Income $2.29M $630K $322K $604K $278K $520K $2.39M $5.00M
Total Stockholders' Equity $381.6M $428.2M $254.0M $304.5M $288.9M $353.7M $407.5M $446.8M
Total Equity $381.6M $428.2M $254.0M $304.5M $291.2M $357.9M $412.6M $453.4M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$230.3M -$121.2M -$44.08M -$64.51M -$4.54M
Depreciation & Amortization $2.62M $1.39M $370K $165K --
Stock-Based Compensation $12.90M $7.28M $7.11M $9.65M --
Change in Payables $20.56M $7.16M $1.58M -$1.31M --
Operating Cash Flow -$196.0M -$116.6M -$42.78M -$55.89M -$611K
Capital Expenditure -$35K -$520K -$284K -$16K --
Free Cash Flow -$196.0M -$117.1M -$43.06M -$55.91M --
Purchases of Investments -$265.4M -$350.3M -$175.7M -$42.23M --
Investing Cash Flow $203.0M -$205.6M -$25.18M -$32.34M --
Share Repurchases -- -$50 $0 $0 --
Financing Cash Flow $146.0M $51.31M $479.7M $119.7M -$58K
Net Change in Cash $154.1M -$270.7M $411.7M $31.47M -$669K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$79.55M -$61.80M -$69.71M -$63.02M -$70.69M -$56.05M -$40.56M -$46.40M
Depreciation & Amortization $905K $896K $845K $751K $745K $742K $378K $364K
Stock-Based Compensation $2.85M $2.55M $13.36M $3.59M $3.71M $3.31M $2.29M $1.93M
Change in Payables -$3.19M -$6.34M -$6.17M $4.27M $8.20M $5.07M $3.01M -$1.72M
Operating Cash Flow -$63.40M -$55.56M -$66.29M -$58.79M -$44.54M -$54.53M -$38.14M -$48.47M
Capital Expenditure $0 $0 $0 $0 $0 $0 -$35K -$176K
Free Cash Flow -$63.40M -$55.56M -$66.29M -$58.79M -$44.54M -$54.53M -$38.17M -$48.65M
Purchases of Investments -$88.29M -$58.75M -$59.07M -$59.17M $0 -$117.7M -$88.55M -$146.9M
Investing Cash Flow -$58.76M $322K $98K -$29.91M $88.40M $88.25M $56.25M -$147.3M
Common Stock Issued -- $44.31M $6.01M -- $0 $0 $0 --
Share Repurchases -- -- -- -- -- -- -- $0
Financing Cash Flow $26.97M $234.6M $30.64M $72.39M $480K $0 $73.12M $151K
Net Change in Cash -$95.22M $179.4M -$36.03M -$16.22M $44.05M $35.12M $91.14M -$195.2M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -74.7% -26.6% -7.3% -102.2% --
Return on Assets (ROA) -53.6% -24.9% -6.8% -65.0% -46.9%
Current Ratio 9.27x 21.11x 51.59x 9.98x 0.46x
Quick Ratio 8.66x 19.95x 51.28x 9.41x 0.38x
Debt to Equity 0.25x 0.01x 0.01x 0.01x --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -71.7% -61.6% -101.2% -74.7% -72.9% -49.8% -35.6% -26.6%
Return on Assets (ROA) -50.6% -45.9% -64.2% -53.6% -50.8% -38.3% -28.4% -24.9%
Current Ratio 9.13x 12.56x 8.60x 9.27x 8.50x 16.65x 21.11x 21.11x
Quick Ratio 8.53x 11.83x 7.76x 8.66x 7.87x 15.54x 20.02x 19.95x
Debt to Equity 0.27x 0.24x 0.40x 0.25x 0.26x 0.21x 0.19x 0.01x
Source: SEC EDGAR CompanyFacts (CIK 0001821586) · from September 30, 2020 Data through September 30, 2026 · synced Nov 20, 2026, 05:29 UTC · Open in terminal